USP THE TOP 10 THINGS YOU NEED TO KNOW 800_6 slides per page.pdfStandard Hand Delivery, but do not...
Transcript of USP THE TOP 10 THINGS YOU NEED TO KNOW 800_6 slides per page.pdfStandard Hand Delivery, but do not...
10/4/18
1
USP <800> THE TOP 10 THINGS YOU NEED TO KNOWChristina Coleman Kim, PharmD
University of New Mexico Hospitals
Christina Kim 2
#1Go Live Date
Christina Kim
• DECEMBER 1, 2019
• New Mexico Board of Pharmacy is currently re-writing Title 16, Chapter 19, Part 30 (Compounding of Non-Sterile Pharmaceuticals) and Part 36 (Compounded Sterile Preparations) to include USP <800> regulations
• What does this mean for hazardous compounding in New Mexico facilities?• We have approximately 14 months to bring our
facilities into compliance with the new regulations• The New Mexico Board of Pharmacy will require
compliance and will be inspecting for compliance as of December 1, 2019.
• Get it done early because you’ll have a lot of people to reach out to!
3
GO LIVE INFORMATION
Christina Kim 4
#2 Introduction and Scope
Christina Kim
• WHAT ARE WE DISCUSSING?• Handling Hazardous Drugs (HDs)
• WHY ARE WE DISCUSSING HANDLING HAZARDOUS DRUGS?• To create standards for handling because we care
about patient safety, employee safety and protecting the environment
• WHO IS AFFECTED?• Anyone and any institution that handles HD
preparations
• SHARE WHAT WE HAVE AT UNMH
5
INTRODUCTION AND SCOPE
Christina Kim 6
#3Designated Person
10/4/18
2
Christina Kim
• RESPONSIBILITIES OF DESIGNATED PERSON• Qualified and trained• Oversee compliance with USP <800> as well as other applicable
laws and regulations• Competency of personnel• Environmental control of storage and compounding areas• Oversight of facility including testing and monitoring• Maintaining documentation
• DOES THE “DESIGNATED PERSON” HAVE TO DO EVERYTHING?• No, form an interdisciplinary team consisting of nurses,
pharmacists, pharmacy technicians, physicians, veterinarians, safety personnel, environmental services personnel, etc.
7
DESIGNATED PERSON TO MANAGE THE PROGRAM
Christina Kim 8
#4LIST OF HAZARDOUS
DRUGS
Christina Kim
• ENTITY MUST CREATE AND MAINTAIN A LIST OF HDs• A list of HDs is maintained by The National Institute for
Occupational Safety and Health (NIOSH)• Group 1: Antineoplastic Drugs which may pose a reproductive
risk for susceptible populations• Group 2: Non-antineoplastic drugs that meet one or more of
the NIOSH criteria for a hazardous drug and may also pose a reproductive risk for susceptible populations
• Group 3: Drugs that pose a reproductive risk to both men and women who are actively trying to conceive and women who are breast feeding
• NIOSH 2016 List plus a proposed addition list for 2018• Practice-specific assessment of HDs which is evaluated yearly or
whenever a new agent is added to the formulary• Perform an assessment of risk of the drugs on your list to
determine how to handle HDs
9
LIST OF HAZARDOUS DRUGS
Christina Kim
• IT IS ADVISEABLE TO PERFORM AN ASSESSMENT OF RISK (AOR) OF ALL DRUGS ON YOUR HAZARDOUS DRUG LIST• Why? Provides for alternative containment strategies and
work practices.• HDs on the NIOSH List that must follow containment
requirements of USP <800> regardless of AOR include• Any HD API
• Any antineoplastic requiring manipulation
• Alternative containment strategies and work practices are allowed for drugs on the NIOSH list if an AOR is completed
• Final dosage forms of compounded HD preparations
• Conventionally manufactured HD products that do not require any further manipulation
10
ASSESSMENT OF RISK
Christina Kim
• TOPICS TO INCLUDE IN THE AOR:1. Type of HD2. Dosage form (Every form of every drug on the NIOSH list)3. Risk of exposure4. Packaging5. Manipulation6. Administration (PPE)
• EXAMPLES 1. Final dosage form of compounded antineoplastics (An
AOR may reveal the need for less restrictive storage requirements)
2. Finasteride (crushing tablets on the floor) (An AOR may reveal the need for more restrictive requirements.)
11
ASSESSMENT OF RISK
Christina Kim
Step 1: Create an Algorithm
12
NIOSH Table 2 or is carcinogenic, genotoxic, or organ toxic (per criteria in NIOSH guidelines)
Injectable
Requires drawing from ampule or vial?
Yes:
Storage: Standard
Hood: C-PEC
Pharmacy garb: Full PPE
Hand delivery non-chemo
Nursing Garb: Chemo gloves
No, in final dosage form:
Storage: Pyxis
Hood: N/A
Pharmacy garb: N/A
Delivery: OK to tube
Nursing Garb: Chemo gloves
Solution, Topical
Requires manipulation such as mixing?
Yes:
Storage: Standard
Hood: C-PEC
Pharmacy garb: Full PPE
Hand Delivery non-chemo
Nursing Garb: Chemo gloves
If not, then it's in its final dosage form
Storage: Pyxis
Hood: N/A
Pharmacy garb: N/A
Delivery: OK to tube
Nursing garb: Chemo gloves
Tablet, Capsule
Requires manipulation sucRequires manipulation such as crushing or splitting
tablets or opening capsules?
Yes:
Storage: Standard
Hood: C-PEC
Pharmacy garb: Full PPE
Hand Delivery non-chemo
Nursing Garb: Chemo gloves
If not, then it's in its final dosage form
Storage: Pyxis
Hood: N/A
Pharmacy garb: N/A
Delivery: OK to tube
Nursing garb: Chemo gloves
• Present it to your group and discuss• Pick what factors are important and come
up with a consistent set of rules
• You could try to evaluate each drug and each form one-by-one• After you include all of the forms of each
drug you are looking at a list 300 lines long!
• That’s too much for a group discussion
• Dividing and conquering list-by-list can lead to inconsistency
10/4/18
3
Christina Kim
Step 2: Load Your Algorithm Rules into Excel
13
• The NIOSH list is not Excel friendly but you can do it!• Make a bunch of If-Then Statements in Excel based on the
algorithm your group decided on and just drag it through your NIOSH Excel
• You will end up with a big, overwhelming Excel sheet that only the safety nerds will appreciate
• It will only take one, hour-long meeting for the algorithm• From there give one person about two extra hours to set up
the Excel and you’re done!• If you want to change the algorithm later, just update the
Excel rules!
Christina Kim 14
UNMH Assessment of Risk• Do not crush or open any forms of drugs on this list on a nursing unit or anywhere outside of a pharmacy Hazardous hood.• When administration of a drug requires that pharmacy manipulate any nonsterile HD on this list such as splitting tablets, crushing tablets or opening capsules to create a slurry, administering personnel must wear two pairs of gloves and a gown.• The information in this list can be found on the MAR and Pyxis stations.• Most NIOSH Group 1 drugs are cytotoxic chemotherapy. Cytotoxic drugs will be stickered with a yellow warning sticker that states, "CYTOTOXIC MATERIAL HANDLE PROPERLY."• NIOSH Group 2 drugs are non-antineoplastic drugs that meet one or more of the NIOSH criteria for an HD, some of these HDs may pose a reproductive risk for susceptible populations.• NIOSH Group 3 drugs primarily pose a reproductive risk to men and women who are actively trying to conceive and women who are pregnant or breast feeding.• Solid form drugs generally pose less risk of exposure than injectable and non-solid form drugs and thus are handled differently.
Drug Information Pharmacy Handling Nursing Unit Handling Additional Information
Generic Name (Brand Name)
Usual Route
FormulationPharmacy Storage
Pharmacy protection (PPE) for Manipulati
on
What type of Hood to Prepare
(Manipulate)
Dispense from Pharmacy
Disposal
DeliveryNursing
Garb (PPE)Storage in
Pyxis?Excrement/Urine
DisposalSupplemental information
Pregnancy Category
NIOSH Group
MSHGAHFS
classification
abiraterone Oral TabletPyxis or Standard
Haz garb Haz HoodStandard Hand Delivery, but do not tube
Black bucket
Standard Hand
Delivery, but do not
tube
One pair of gloves
Pyxis or Standard
Protect from
urine/excrement for 48h
Black bucket
Women who are pregnant or may be pregnant should not handle without protection
(e.g., gloves)
XAntineoplastic Group
1
10:00 antineoplastic agents
ado-trastuzumab emtansine
IV Injection Haz RoomHaz garb and use
EquashieldHaz Hood
Hand Deliver in Chemo bag
Black bucket
Hand Deliver in Chemo bag
Double glove and
gown
Hand Delivery in Chemo bag
Protect from
urine/excrement for 48h
Black bucket
Conjugated monoclonal antibody
DAntineoplastic Group
1yes
10:00 antineoplastic agents
afatinib* Oral TabletPyxis or Standard
Haz garb Haz HoodStandard Hand Delivery, but do not tube
Black bucket
Standard Hand
Delivery, but do not
tube
One pair of gloves
Pyxis or Standard
Protect from
urine/excrement for 48h
Black bucket
Special warnings on contraception for
females while taking and 2 weeks post-
treatment
DAntineoplastic Group
1
10:00 antineoplastic agents
altretamine Oral CapsulePyxis or Standard
Haz garb Haz HoodStandard Hand Delivery, but do not tube
Black bucket
Standard Hand
Delivery, but do not
tube
One pair of gloves
Pyxis or Standard
Protect from
urine/excrement for 48h
Black bucket
DAntineoplastic Group
1yes
10:00 antineoplastic agents
amsacrine IV Injection Haz RoomHaz garb and use
EquashieldHaz Hood
Hand Deliver in Chemo bag
Black bucket
Hand Deliver in Chemo bag
Double glove and
gown
Hand Delivery in Chemo bag
Protect from
urine/excrement for 48h
Black bucket
IARC Group 2B†Antineoplastic Group
1yes
NA antineoplastic agents
anastrozole Oral TabletPyxis or Standard
Haz garb Haz HoodStandard Hand Delivery, but do not tube
Black bucket
Standard Hand
Delivery, but do not
tube
One pair of gloves
Pyxis or Standard
Protect from
urine/excrement for 48h
Black bucket
XAntineoplastic Group
1
10:00 antineoplastic agents
arsenic trioxide
IV Injection Haz RoomHaz garb and use
EquashieldHaz Hood
Hand Deliver in Chemo bag
Aresenic
bucket
Hand Deliver in Chemo bag
Double glove and
gown
Hand Delivery in Chemo bag
Protect from
urine/excrement for 48h
Return to pharmacy
for disposal
in arsenic bucket
IARC Group 1 carcinogen; NTP**
DAntineoplastic Group
1yes
10:00 antineoplastic agents
axitinib Oral TabletPyxis or Standard
Haz garb Haz HoodStandard Hand Delivery, but do not tube
Black bucket
Standard Hand
Delivery, but do not
tube
One pair of gloves
Pyxis or Standard
Protect from
urine/excrement for 48h
Black bucket
Teratogenic, embryotoxic and
fetotoxic in mice at exposures lower than
human exposures
DAntineoplastic Group
1
10:00 antineoplastic agents
azacitidine IV Injection Haz RoomHaz garb and use
EquashieldHaz Hood
Hand Deliver in Chemo bag
Black bucket
Hand Deliver in Chemo bag
Double glove and
gown
Hand Delivery in Chemo bag
Protect from
urine/excrement for 48h
Black bucket
IARC Group 2A carcinogen; NTP***
DAntineoplastic Group
1yes
10:00 antineoplastic agents
Bacillus Calmette
Guerin (BCG)
Catheter
Injection Haz RoomHaz garb and use
EquashieldHaz Hood
Hand Deliver in Chemo bag
Black bucket
Hand Deliver in Chemo bag
Double glove and
gown
Hand Delivery in Chemo bag
Protect from
urine/excrement for 48h
Black bucket
See special handling requirements‡; FDA
Pregnancy Category CC
Antineoplastic Group
1yes
80:12 vaccines
Christina Kim
Step 3 Collaborate!This is a Great Way to Get Pharmacy out there in your Facility!
15
• Use it as an excuse to get on agendas and network!• Adult Nurse/Pharmacy• Peds Nurse/Pharmacy• Med Safety• Safety Directors meeting• Clin Ed• PPG• Management Coffee
• Make sure its safe AND practical!• Participate in Nursing Education on USP 800!• Build it into your MAR and on to Pyxis• Work with IT and make it nursing-friendly!
Christina Kim 16
#5RECEIVING HDs
Christina Kim
PROCEDURE REQUIRED FOR RECEIVING HDS1. Visually examine the shipping container for signs of
damage or breakage and follow entity’s developed procedure for handling damaged or broken containers
2. The supplier should package HDs in impervious plastic to segregate them from other drugs. Leave the HDs in the plastic and deliver to the HD storage area for further unpacking
3. PPE, including chemotherapy gloves, must be worn when unpacking (This is where the AOR comes in to play)
4. Remove HDs from their external shipping containers in an area that is neutral or negative pressure relative to the surrounding areas.
5. Do not unpack in the sterile compounding area or in any positive pressure area
6. A spill kit must be accessible in the receiving area
17
REQUIREMENTS FOR RECEIVING HDs
Christina Kim 18
#6STORING HDs
10/4/18
4
Christina Kim
PROCEDURE REQUIRED FOR STORING HDs1. Do not store on the floor. Store on secure shelves
with raised front lips to prevent falling and breaking2. Antineoplastic HDs and HD API requiring physical
manipulation must be stored in an externally vented, negative pressure room with at least 12 air changes per hour (ACPH). Example: Hazardous Ante or Clean room
3. Non-antineoplastic, reproductive risk only, and final dosage forms of antineoplastic HDs may be stored with other inventory if permitted by entity policy. Examples: methotrexate, finasteride and warfarin tabs
19
REQUIREMENTS FOR STORING HDs
Christina Kim
PROCEDURE REQUIRED FOR STORING HDs4. Refrigerated antineoplastic HDs must be stored in a dedicated
refrigerator in a negative pressure area with at least 12 ACPH. Examples: storage room, buffer (clean) room or containment segregated compounding area (C-SCA). Note: It is recommended to place the refrigerator in front of an exhaust vent if the refrigerator is located in a negative pressure buffer (clean) room
5. The most simple approach to take (if your procedures allows) is to store sterile HDs that require manipulation in a properly designed storage room, hazardous ante or clean room or the C-SCA. Store non-sterile HDs such as tablets or suspensions with other inventory
20
REQUIREMENTS FOR STORING HDs
Christina Kim 21
#7COMPOUNDING HDs
Christina Kim
PRACTICAL APPROACH TO COMPOUNDING• Training• Personal Protective Equipment• Facilities and Engineering Controls• Containment Supplemental Engineering
Controls• Non-sterile compounding
22
COMPOUNDING
Christina Kim
Engineering Controls: NIOSH/OSHA term that describes a barrier between the worker and HD• Primary Engineering Control: • Containment Primary Engineering Control (C-PEC):
Haz-hood• Secondary Engineering Control: • Containment Secondary Engineering Control (C-SEC):
Haz-room• Containment segregated compounding area (C-SCA):
Basically a less sterile C-SEC• Unclassified area: Everywhere else in the world• Supplemental Engineering Control: Closed-System Drug-
Transfer Device (CSTD)• Equashield, Phaseal, etc
23
Definitions
Christina Kim
TRAININGSTERILE HAZARDOUS COMPOUNDING
1. TRAINING IN NON-HAZARDOUS STERILE COMPOUNDING IS REQUIRED PRIOR TO BEGINNING HAZARDOUS STERILE COMPOUNDING TRAINING
2. Once non-hazardous compounding training is complete and employee demonstrates competency then hazardous compounding training can begin
3. The following are required areas of training for any type of hazardous compounding:• Overview of entity’s list of HDs and risks • Review of the entity’s policies and procedures for handling HDs• Proper Use of Personal Protective Equipment• Proper Use of equipment and devices• Response to known or suspected HD exposure• Spill Management • Proper disposal of HDs and trace-contaminated materials
24
10/4/18
5
Christina Kim
PERSONAL PROTECTIVE EQUIPMENT
1. GLOVES [American Society for Testing and Materials (ASTM) D6978]• Two pairs of gloves are required. The outside gloves must be sterile• Change gloves every 30 minutes or when torn, punctured or contaminated• Wash hands with soap and water after removing gloves
2. GOWNS [Polyethylene-coated polypropylene or other laminate materials]• Disposable• Long sleeved• Close in the back (tie in the back)• Closed cuffs that are elastic or knit• Change every 2-3 hours or per the manufacturer’s information. Change immediately
after a spill or splash• Do not wear the gown outside of the hazardous medication preparation area
25 Christina Kim
PERSONAL PROTECTIVE EQUIPMENT
3. HEAD, HAIR, SHOE, AND SLEEVE COVERS• Cover head and hair. Cover beard and moustache with a beard cover• When entering the hazardous compounding area a second set of shoe covers
must be donned before entering and doffed when exiting the compounding area• Disposable sleeve covers may be used (polyethylene-coated polypropylene or
other laminate materials offer better protection
4. EYE AND FACE PROTECTION• Eye protection is typically not used when compounding inside an appropriate biological safety cabinet• However, goggles must be worn when eye protection is needed• Face shields in combination with goggles provide full protection against splashes to the eyes and face
26
Christina Kim
PERSONAL PROTECTIVE EQUIPMENT
5. RESPIRATORY PROTECTION• Interestingly enough – USP <800> doesn’t give a recommendation for respiratory protection if
working with a face shield in an appropriate biological safety cabinet• USP <800> does state that “surgical masks do not provide respiratory protection from drug exposure and must
not be used when respiratory protection from HD exposure is required”• Remember a mask ensures sterility of the product but even an N-95 doesn’t do much to protect the worker
6. DISPOSAL OF PPE USED DURING COMPOUNDING• Place in an appropriate waste container inside the containment secondary engineering control area (C-
SEC) also known as the hazardous clean room and dispose of per local, state, and federal regulations• Remove chemotherapy gloves and sleeve covers used during compounding and discard immediately
into an appropriate waste container inside the contained primary engineering control unit (C-PEC). You may also place gloves and sleeves into a sealable bag and discard into an appropriate waste container outside of the C-PEC such as an appropriate container located in the C-SEC. This second option is a little more practical due to space inside the C-PEC
• Need to don PPE upon entering and doff PPE BEFORE leaving the haz room • Can’t run things out of the Haz room and re-enter anymore
27 Christina Kim
FACILITIES AND ENGINEERING CONTROLS
In order to compound appropriately and safely understand the facility, design and
engineering controls is crucial
28
1 2
3 4
5 6
Christina Kim
USP <797> AND <800> FACILITY DESIGN FOR STERILE COMPOUNDING
NEGATIVE PRESSURE – ISO 7 – HAZARDOUS COMPOUNDINGEXTERNALLY VENTED TO
OUTSIDE AIR
SHARED ANTE ROOM –ISO 7
POSITIVE PRESSURE BUFFER ROOM – ISO 7 – NON-HAZARDOUS
COMPOUNDING – RECIRCULATE AIR THROUGH HEPA FILTERS OR VENT
TO THE OUTSIDE
29
Laminar Air Flow Hood (LAFH)
Class II B2 BSC
ISO 5
Christina Kim
USP <797> AND <800> FACILITY DESIGN FOR HD STERILE COMPOUNDING – Unclassified Containment-Segregated Compounding Area (C-SCA) – Requires 12 hour BUD
NEGATIVE PRESSURE –Relative to adjacent area
(0.01 – 0.03 in WC) EXTERNALLY VENTED TO
OUTSIDE AIR
30
Class II B2 BSC
10/4/18
6
Christina Kim
PRIMARY ENGINEERING CONTROLContainment Primary Engineering Controls (C-PECS) NOT ALLOWED for STERILE compounding of HDs
31
Laminar Air Flow Hood (LAFH)
Containment Ventilated Enclosure
(CVE)
Can be used for Non-Sterile Compounding Class 1 BSC
Fume Hood (protects worker but not product)
Christina Kim
PRIMARY ENGINEERING CONTROLContainment Primary Engineering Controls (C-PECS) ALLOWED for STERILE compounding of HDs
32
Containment Ventilated Enclosure
(CVE)
Can be used for Non-Sterile Compounding
Christina Kim
Compounding aseptic containment isolator (CACI)
• Note that 797 update will require that you put disposable gloves on your hands, then put your gloved hands into the gloves then put gloves on top of the gloves
• 3 pair of gloves!
• You still need to put it into a negative pressure room
33
PRIMARY ENGINEERING CONTROL – One more!
Christina Kim
CONTAINMENT SUPPLEMENTAL ENGINEERING CONTROLS (CSTDs)Keyword: Supplemental Not a substitute for a C-PEC
• Offer an additional level of protection during compounding and administration• A “Should” for preparation, but a “Must” for administration?
• Many Brands in the Marketplace. Examples:• Equashield• Icumedical – ChemoLock• BD Phaseal• Tevadaptor
COMPOUNDING ADMINISTRATION
34
Christina Kim
NON-STERILE COMPOUNDING• Must also follow standards set in Pharmaceutical Compounding-Nonsterile Preparations <795>
• Handling of final dosage forms in a C-PEC is not required unless you are manipulating in such a way that produces particles, aerosols or gasses
• If you are manipulating a non-sterile HD then the following table is helpful to determine where to compound:
• A C-PEC designated for sterile compounding may be used to occasionally compound non-sterile HD. However, the C-PEC must be decontaminated, cleaned and disinfected before resuming sterile compounding
35
Engineering Controls for Nonsterile HD Compounding
C-PEC Requirements C-SEC Requirements
• Externally vented (preferred) or redundant-HEPA filtered in series
• Examples: CVE, Class I or II BSC, CACI
• Externally vented• 12 ACPH• Negative Pressure (0.01
and 0.03 inches of water column) relative to adjacent areas
Christina Kim
Engineering Controls: Preferred ISO Class 7 buffer room with ISO Class 7 ante room• Not recommended to enter the haz room through the non-haz
room (ante-room preferred)• But if you do, a method of transportation of HDs is
required. It’s basically required to have a pass-through• Wipe sampling twice per year• Talk with your CSTD rep ;)
36
Other Recommendations
10/4/18
7
Christina Kim 37
#8ADMINISTERING HDs
Christina Kim
• No NIOSH medication should be crushed on the units?• What about paediatric patient education (methotrexate)?• It’s a SHOULD NOT in USP 800, use a plastic pouch and PPE if
absolutely necessary• Now you have a Do-Not Crush list and the NIOSH list• Time to put this info onto the MAR and Pyxis
• Use CSTDs for administration when possible (It’s mandatory)• Have Chemo-experienced nurses float to administer chemo• PPE: all of our gloves at UNMH are “Chemo gloves”• 2 pair for anti-neoplastic HDs• 2 versus 1 for the rest depends on your assessment of risk• Eye, face, and respiration protection is optional• Refer to Oncology Nursing Society guidelines ONS for more
details on PPE
38
Help the Nurses!
Christina Kim 39
#9SPILL CONTROL of HDs
Christina Kim
In addition to PPE requirements described, its up to you to work with work with EVS and Safety on this one!• Develop SOPs and train your staffAt UNMH• Our Spill SOP is built into our USP 800 guideline• Double-bag contaminated linen blue then yellow on the outside• Spills less than 5ml• No spill kit necessary
• Spills greater than 5ml• Use a spill kit
40
Spills!
Christina Kim 41
#10MEDICAL SURVEILLANCE
Christina Kim
• Does every person exposed to chemo need a trip to the ED?• Consider running this by the ED before putting it in writing!• Be careful who you mandate goes to the ED• Our ED does not feel every drop of chemo requires an
emergency visit• Eye exposure, ingestion, symptomatic skin and symptomatic
inhalation require immediate treatment• Send patients, visitors and workers to Oc Health or ED• Injections, rectal, nasal exposure, need immediate help as
well• Work with your Occupational Health team
42
Accidental Exposure!
10/4/18
8
Christina Kim 43
Conclusion
Christina Kim
USP 800 is a big deal and its our time to shine!
• Recruit a multidisciplinary team• Come up with your own procedure and make it practical and
specific for your institution• Parade around your work!• Use it as a networking opportunity for your department and
our profession!
44
Wow them with Pharmacy!
Christina Kim
References
1. NIOSH [2016]. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. By Connor TH, MacKenzie BA, DeBord DG, Trout DB, O’Callaghan JP. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication Number 2016-161.
2. New Mexico Board of Pharmacy Regulation. Title 16: Occupational and Professional Licensing. Chapter 19: Pharmacists. Part 30: Compounding of Non-Sterile Pharmaceuticals
3. New Mexico Board of Pharmacy Regulation. Title 16: Occupational and Professional Licensing. Chapter 19: Pharmacists. Part 36: Compounded Sterile Preparations
4. <800> Hazardous Drugs – Handling in Healthcare Settings. United States Pharmacopoeia.
45
1 2
3 4
5 6
Thank [email protected]